MyFinsight
Home
Blog
About
Back
Income Statement
Aligos Therapeutics, Inc. (ALGS)
Aligos Therapeutics, Inc. (ALGS)
source: myfinsight.com
Comprehensive (loss) income
-$1,505K
(90.53%↑ Y/Y)
Change in fair value of
2023 common warrants
-$2,976K
(-76.93%↓ Y/Y)
Interest and other
income, net
$221K
(-81.69%↓ Y/Y)
Net (loss) income
-$1,504K
(90.52%↑ Y/Y)
Other comprehensive
loss
-$1K
(96.30%↑ Y/Y)
Income (loss) before
income tax
$1,307K
(108.34%↑ Y/Y)
Loss from operations
-$1,890K
(89.82%↑ Y/Y)
Revenue from licensing
agreements
$27,778K
(2778.55%↑ Y/Y)
Income tax provision
$2,811K
(1419.46%↑ Y/Y)
Unrealized loss on
available-for-sale securities
-$1K
(96.30%↑ Y/Y)
Total operating
expenses
$29,668K
(51.89%↑ Y/Y)
Research and development
$24,050K
(72.08%↑ Y/Y)
General and
administrative
$5,618K
(1.12%↑ Y/Y)
Back